Biofrontera Inc. (BFRI) vs TherapeuticsMD, Inc. (TXMD)
- Biofrontera Inc. BFRI 0.82 −3.53%
- TherapeuticsMD, Inc. TXMD 1.90 −1.55%
Biofrontera Inc. and TherapeuticsMD, Inc. are both Drug Manufacturers Specialty & Generic companies. TherapeuticsMD, Inc. is the larger, with a market value of $22.3M against $12.6M — 1.8× the size. TherapeuticsMD, Inc. grew revenue faster over the last twelve months: 27.8% against 17.8%. TherapeuticsMD, Inc. has the higher net margin (−6.64% vs −13.8%) and the higher return on invested capital (−13.8% vs −69.5%). Across the 18 metrics below, TherapeuticsMD, Inc. leads on 13 and Biofrontera Inc. on 5.
Valuation
Profitability
| Metric | BFRI | TXMD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 79.25% | 100.00% | 53.94% |
| Operating margin | (14.22%) | (120.89%) | 0.00% |
| Net margin | (13.78%) | (6.64%) | 0.00% |
| Free cash flow margin | (17.17%) | 94.71% | 0.00% |
| Return on equity | (988.35%) | (0.80%) | (0.40%) |
| Return on assets | (28.80%) | (0.57%) | (3.32%) |
| Return on invested capital | (69.45%) | (13.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack